ACM Home Page
Please provide us with feedback. Feedback
A logical framework for detecting anomalies in drug resistance algorithms
Full text PdfPdf (772 KB)
Source
ACM International Conference Proceeding Series archive
Proceedings of the 2009 International Database Engineering & Applications Symposium table of contents
Cetraro - Calabria, Italy
SESSION: Full papers table of contents
Pages 23-30  
Year of Publication: 2009
ISBN:978-1-60558-402-7
Authors
L. Caroprese  Università della Calabria, Cosenza, Italy
P. M. A. Sloot  University of Amsterdam, The Netherlands
B. Ó. Nualláin  University of Amsterdam, The Netherlands
E. Zumpano  Università della Calabria, Cosenza, Italy
Sponsors
: BytePress
Concordia University : Concordia University
: ACM
: Universita della Calabria, Rende(CS), Italy
: ICAR-CNR, Rende (CS), Italy
: ACM International Conference Proceeding Series
Publisher
ACM  New York, NY, USA
Bibliometrics
Downloads (6 Weeks): 3,   Downloads (12 Months): 3,   Citation Count: 0
Additional Information:

abstract   references   index terms  

Tools and Actions: Review this Article  
DOI Bookmark: Use this link to bookmark this Article: http://doi.acm.org/10.1145/1620432.1620436
What is a DOI?

ABSTRACT

Virology research is nowadays a discipline involving a broad number of researchers gathered in different institutes and cooperating on defined issues. An example of such an endeavor is the research tackling anti-HIV treatment problems [7] conducted within the Virolab project. The main objective of the ViroLab project is to develop a Virtual Laboratory for Infectious Diseases that facilitates medical knowledge discovery and decision support for HIV drug resistance. Large, high quality in-vitro and clinical patient databases which can be used to relate genotype to drug-susceptibility phenotype have become available. The core of the ViroLab Virtual Laboratory is a rule-based ranking system. More specifically, using a Grid-based service oriented architecture, Virolab vertically integrates the biomedical information from viruses (proteins and mutations), patients and literature (drug resistance experiments), resulting in a rule-based decision support system for drug ranking. This paper is a contribution to virologists, epidemiologists and clinicians in medical knowledge discovery and decision support. The final aim is reasoning on the properties of algorithm modeling the interaction among drugs and HIV virus and detecting its anomalies such as rules that can never be satisfied and subset of rules that are in contradiction.


REFERENCES

Note: OCR errors may be found in this Reference List extracted from the full text article. ACM has opted to expose the complete List rather than only correct and linked references.

 
1
Algorithm specification interface (asi). http://hivdb.stanford.edu/pages/asi/.
 
2
Hiv drug resistance database - stanford university. http://hivdb.stanford.edu/.
 
3
Retrogram. http://www.openclinical.org/aisp_retrogram.html.
 
4
The virolab project. http://www.virolab.org/.
 
5
Xml. http://www.w3.org/XML/.
 
6
P. M. A. Sloot. Virolab: from the molecule to the man. eStrategies Projects, (4):53--55, 2008.
 
7
P. M. A. Sloot, P. Coveney, G. Ertaylan, V. Muller, C. Boucher, and M. T. Bubak. Hiv decision support: From molecule to man. Phil. Trans. R. Soc. A, 367(1898), 2009.
 
8
P. M. A. Sloot, P. V. Coveney, M. T. Bubak, A. M. Vandamme, B. Ó Nualláin, D. van de Vijver, and C. A. B. Boucher. Virolab: A collaborative decision support system in viral disease treatment. Reviews in Antiviral Therapy, Virology Education, 3:4--7, 2008.
 
9
P. M. A. Sloot, A. Tirado-Ramos, I. Altintas, M. T. Bubak, and C. A. B. Boucher. From molecule to man: Decision support in individualized e-health. IEEE Computer, (Cover feature), 39(11):40--46, 2006.